Tokyo, Japan- June 22, 2026: SDKI Analytics conducted a survey on smart inhaler devices market, covering key aspects like evolving industry trends, technological advancements, along with market size and share between 2026 and 2035
Detailed insights from the market research report are available at:
https://www.sdki.jp/reports/smart-inhaler-devices-market/590642472
Smart Inhaler Devices Market Report Highlights:
- Report Release Date: June 22, 2026
- Research Organization: SDKI Analytics
- Study Coverage: Global
- Forecast Period: 2026–2035
- Base Year: 2025
- Survey Scope: Our analysts conducted a survey of 555 market players. The size of the players surveyed varied.
- Survey Locations: North America (United States and Canada), Latin America (Mexico, Brazil, Argentina, and Rest of Latin America), Europe (Germany, United Kingdom, France, Italy, Spain, Nordic Countries, and Rest of Europe), Asia Pacific (Japan, China, India, South Korea, ASEAN Countries, Australia, and Rest of Asia Pacific), and Middle East & Africa (GCC, South Africa, North Africa, and Rest of MEA).
- Survey Methodology: 222 on-site surveys, 333 online surveys.
- Survey Period: April 2026 – May 2026
Smart Inhaler Devices Market Report Scope
This report provides a comprehensive assessment of the smart inhaler devices market, including:
- Growth Drivers and Restraints
- Emerging Opportunities
- Technological And Regulatory Trends
- Competitive Landscape Analysis
- Market Segmentation Analysis
- Regional And Country-Level Insights, Including Japan
Smart Inhaler Devices Market Snapshot
According to the latest analysis by SDKI Analysis, the SMART INHALER DEVICES market size was US$ 22.1 billion in 2025 and is expected to reach US$ 131.8 billion by 2035, registering a CAGR of around 19.6% throughout the forecast period.
As per our analysts, the market is expected to witness substantial growth due rising prevalence of chronic obstructive pulmonary disease (COPD) in aging population and occupational exposure. Several reports state that COPD is one of the leading causes of death, driven by aging population and long-term exposure to occupational dust and chemicals.
The World Health Organization (WHO) states that COPD affected more than 390 million people in 2025, an increase of 15% since 2020, highlighting the growing need for advanced respiratory devices, including smart inhaler devices.
Moreover, rising adoption of telemedicine and remote patient monitoring is expected to fuel the market growth in the coming years. As healthcare providers are shifting towards virtual care and home based disease management, smart inhalers are becoming valuable tools for monitoring patients with asthma, COPD, and other respiratory diseases.
Smart Inhaler Devices Market Recent Industry Developments
According to our research, leading companies operating in the smart inhaler devices market have recently announced the following developments:
- In March 2025, Aerogen announced the opening of its global-standard respiratory care to Delhi, India.
- In July 2023, Teva announced the launch of GoResp Digihaler, a digitally-enabled inhaler in the UK for patient with asthma and COPD.
Smart Inhaler Devices Market Segmentation
Our smart inhaler devices market research segments the market by product type into metered dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers. Among these, the MDIs segment is expected to account for largest share of 42% over the forecast period, attributed to its established market presence, portability, and ease of use and widespread adoption in the treatment of asthma and COPD.
MDIs remain one of the most commonly prescribed inhalation devices globally due to their ability to deliver precise and consistent doses of medication directly to the lungs. The increasing integration of digital sensors and connectivity features into MDIs is further enhancing medication adherence, remote patient monitoring, and dose tracking capabilities.
Smart Inhaler Devices Market Regional Overview
According to our analysis of the smart inhaler devices market, North America is expected to account for largest share of 44% between 2026 and 2035 attributed to high prevalence of asthma and COPD, growing focus on medication adherence, and presence of well-established telemedicine and remote patient monitoring.
In Japan, aging population coupled with growing incidence of respiratory diseases like asthma, and COPD, and government-led healthcare digitalization is fueling the market growth.
Major players in the Smart Inhaler Devices Market
As stated in our research report, the most prominent players in the global smart inhaler devices market are:
- AptarGroup / Aptar Pharma
- Adherium Limited
- FindAir Sp. z o.o.
- Amiko Digital Health
- Smart Respiratory Products Ltd
In addition, the top 5 players in the Japanese market are as follows:
- Micron Co., Ltd.
- OMRON Healthcare Japan
- A&D
- Panasonic
- AMCO
Company Profile:
SDKI Analytics’ goal is to provide reliable and in-depth market research and insights. We focus not only on researching and delivering detailed market reports on growth metrics, challenges, trends, and the competitive landscape, but also on completely transforming our clients’ businesses for maximum growth and success. Our market research analysts have extensive experience working with companies of all sizes across various industries and market segments.
Related Reports:
- Respiratory Care Devices Market
- Drug Delivery Market
- Pulmonary Respiratory Drug Delivery Market
- Nebulizers and Inhalers Market
Contact Information:
- Inquiry Form: https://www.sdki.jp/contact/
- Phone number: +81 50 50509337 (9:00-18:00) (excluding weekends and public holidays)
- URL: https://www.sdki.jp/
SDKI Inc. SNS
- X (Twitter): https://twitter.com/SDKIResearch
- Facebook: https://www.facebook.com/sdkiresearch/
